ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 143 filers reported holding ANIKA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,482 | -28.3% | 831 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $21,589 | -9.5% | 831 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $23,866 | -24.4% | 831 | -22.0% | 0.00% | 0.0% |
Q4 2022 | $31,554 | +24.4% | 1,066 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $25,371 | +6.6% | 1,066 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $23,793 | -11.1% | 1,066 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $26,767 | -83.9% | 1,066 | -77.1% | 0.00% | -50.0% |
Q4 2021 | $166,538 | -15.8% | 4,648 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $197,819 | -1.7% | 4,648 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $201,212 | +6.1% | 4,648 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $189,592 | -9.9% | 4,648 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $210,368 | +27.9% | 4,648 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $164,493 | -6.2% | 4,648 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $175,369 | +18.0% | 4,648 | -9.6% | 0.00% | 0.0% |
Q1 2020 | $148,626 | -44.2% | 5,141 | 0.0% | 0.00% | -25.0% |
Q4 2019 | $266,561 | -5.5% | 5,141 | 0.0% | 0.00% | -20.0% |
Q3 2019 | $282,189 | +35.1% | 5,141 | 0.0% | 0.01% | +25.0% |
Q2 2019 | $208,827 | +34.3% | 5,141 | 0.0% | 0.00% | +33.3% |
Q1 2019 | $155,464 | -10.0% | 5,141 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $172,789 | -20.3% | 5,141 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $216,847 | -99.9% | 5,141 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $164,512,000 | -35.6% | 5,141 | 0.0% | 0.00% | -25.0% |
Q1 2018 | $255,611,000 | +92178.3% | 5,141 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $277,000 | -54.1% | 5,141 | -50.6% | 0.00% | 0.0% |
Q3 2017 | $604,000 | +17.5% | 10,417 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $514,000 | +13.5% | 10,417 | 0.0% | 0.00% | +33.3% |
Q1 2017 | $453,000 | -11.2% | 10,417 | 0.0% | 0.00% | -25.0% |
Q4 2016 | $510,000 | +2.4% | 10,417 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $498,000 | -10.9% | 10,417 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $559,000 | +16.7% | 10,417 | -2.7% | 0.00% | 0.0% |
Q1 2016 | $479,000 | +17.4% | 10,704 | 0.0% | 0.00% | +33.3% |
Q4 2015 | $408,000 | +24.0% | 10,704 | +3.5% | 0.00% | +50.0% |
Q3 2015 | $329,000 | -7.3% | 10,346 | -3.7% | 0.00% | 0.0% |
Q2 2015 | $355,000 | -22.5% | 10,742 | -3.4% | 0.00% | -33.3% |
Q1 2015 | $458,000 | +1.1% | 11,121 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $453,000 | +11.0% | 11,121 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $408,000 | -20.8% | 11,121 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $515,000 | +12.7% | 11,121 | 0.0% | 0.00% | +33.3% |
Q1 2014 | $457,000 | +7.8% | 11,121 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $424,000 | +59.4% | 11,121 | 0.0% | 0.00% | +50.0% |
Q3 2013 | $266,000 | +40.7% | 11,121 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $189,000 | – | 11,121 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,375 | $1,225,000 | 2.02% |
CAPITAL MANAGEMENT CORP /VA | 92,905 | $2,686,000 | 0.98% |
Avidity Partners Management LP | 168,000 | $4,857,000 | 0.67% |
DIKER MANAGEMENT LLC | 21,935 | $634,000 | 0.27% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,327,397 | $38,375,000 | 0.22% |
Intercontinental Wealth Advisors, LLC | 12,468 | $360,000 | 0.19% |
Boston Trust Walden Corp | 326,319 | $9,434,000 | 0.15% |
Matarin Capital Management, LLC | 32,599 | $942,000 | 0.15% |
Cove Street Capital, LLC | 20,000 | $578,000 | 0.12% |
OAKTOP CAPITAL MANAGEMENT II, L.P. | 12,500 | $361,000 | 0.11% |